1 – 9 of 9
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
The role of extracellular vesicle fusion with target cells in triggering systemic inflammation
(
- Contribution to journal › Article
- 2023
-
Mark
Therapeutic S100A8/A9 blockade inhibits myocardial and systemic inflammation and mitigates sepsis-induced myocardial dysfunction
(
- Contribution to journal › Article
- 2019
-
Mark
Osteopontin protects against lung injury caused by extracellular histones
(
- Contribution to journal › Article
-
Mark
Osteopontin protects against pneumococcal infection in a murine model of allergic airway inflammation
(
- Contribution to journal › Article
- 2017
-
Mark
The nonantibiotic macrolide em703 improves survival in a model of quinolone-treated pseudomonas aeruginosa airway infection
(
- Contribution to journal › Article
-
Mark
DNA-fragmentation is a source of bactericidal activity against Pseudomonas aeruginosa
(
- Contribution to journal › Article
- 2016
-
Mark
NLF20: an antimicrobial peptide with therapeutic potential against invasive Pseudomonas aeruginosa infection.
(
- Contribution to journal › Article
-
Mark
Roflumilast increases bacterial load and dissemination in a model of Pseudomononas aeruginosa airway infection
(
- Contribution to journal › Article
- 2014
-
Mark
Antimicrobial effects of helix D-derived peptides of human antithrombin III.
(
- Contribution to journal › Article